Diabetes, Obesity & Metabolism

A Biweekly GLP-1R Agonist Designed With Drug-Free Intervals for Enhanced Efficacy, Receptor Homeostasis and Gastrointestinal Tolerability

By Wei Ding, Qing Liu, Qiong Luo, Xiaojun Yao, Xing-Xing Fan

Experiments in animalsInterventions

The paper

Wei Ding, Qing Liu, Qiong Luo, Xiaojun Yao, Xing-Xing Fan

Macau University of Science and Technology

Diabetes, Obesity & Metabolism, 8 Sep 2026

doi.org/10.1111/dom.71304 PubMed 42712076

Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
Research Square8 Oct 2026
Semaglutide improved heart artery function in pigs
The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
Nature Medicine4 Oct 2026
Semaglutide may protect kidneys by reducing vascular resistance